Is a Banned Veterinary Drug Still Endangering Vultures in TN?
Synopsis
Key Takeaways
- Diclofenac remains a significant threat to vultures despite being banned.
- Three species of Gyps vultures are critically endangered in South Asia.
- Illegal use of diclofenac persists in several regions, particularly Rajasthan.
- Efforts in Tamil Nadu have shown some success, but enforcement challenges remain.
- Stricter regulations and public awareness are crucial for vulture conservation.
Chennai, Dec 18 (NationPress) Researchers from Tamil Nadu have raised a new alarm regarding the persistent danger that a banned veterinary medication poses to India’s critically endangered vultures. A recent comprehensive study has confirmed that diclofenac, which was banned nearly two decades ago, continues to be utilized for treating livestock in various regions across the nation.
The research findings are part of the study titled: "The continued threat of toxic NSAIDs to Critically Endangered Gyps vultures in South Asia," carried out by a team of 13 researchers from 2012 to 2024 and recently published in Bird Conservation International.
The study highlights that three Gyps species endemic to Asia—the white-rumped vulture, red-headed vulture, and long-billed vulture—are still experiencing a decline in numbers due to accidental poisoning.
These birds experience fatal kidney failure when they ingest carcasses from cattle treated with diclofenac, which has been identified as the main cause of the drastic decrease in vulture populations since the 1990s.
Although the Union government imposed a ban on the veterinary use of diclofenac in May 2006 and enacted further restrictions on multi-dose vials in 2015, the drug remains illegally available.
Researchers found that Rajasthan, a state with minimal conservation advocacy, displayed the highest prevalence, with up to 25 percent of pharmacies surveyed continuing to offer diclofenac.
In Tamil Nadu, the Vulture Safe Zones (VSZs) showed better results, but enforcement issues still persist.
S. Bharathidasan, secretary of the conservation organization Arulagam, which assisted in surveying VSZs in the state, noted that over 100 legal actions have been initiated against suppliers, manufacturers, and retailers. He mentioned that diclofenac vials found in Tamil Nadu primarily originated from Karnataka, outside the VSZ, where conservation outreach is limited.
The research also indicates that access to veterinary NSAIDs is uneven, with 64.3 percent of pharmacies in Tamil Nadu and 100 percent in Rajasthan providing them.
Much of the diclofenac found was stocked in 3-ml vials—permitted for human use but prohibited for veterinary applications, creating a loophole for misuse.
While the Centre has also banned ketoprofen and aceclofenac since July 2023, Tamil Nadu has proactively restricted flunixin usage in critical vulture habitats like The Nilgiris, Erode, and Coimbatore since 2019, and curtailed ketoprofen as early as 2015.
However, researchers caution that simply banning known toxic drugs is insufficient if untested alternatives with similar risks emerge. They stressed the importance of preventing the diversion of human-use vials for veterinary purposes and ensuring stringent enforcement, warning that vulture populations will remain at risk unless the illegal use of diclofenac is eradicated both statewide and nationally.